SeaStar Medical Holding Corp ICU
Medical/Dental Instruments · IPO 2021 · data as of November 13, 2026
SeaStar Medical Holding Corp (ICU) is a healthcare company listed in the US with a market value of about $4M. In the twelve months to September 30, 2026 it had revenue of $2M and net income of -$15M, a net margin of -678.2%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (3/5); the weakest is track record (0/5).
Key numbers: a 5-year average ROIC of -88%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 29% above the current price.
About SeaStar Medical Holding
SeaStar Medical Holding is listed in the US and classified in medical/dental instruments, IPO year 2021. It was profitable in 0 of the last 5 years in our data. Its share count rose by 531% over three years (dilution for shareholders). It spends 609% of revenue on research and development.
Score: 1.2 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- Profit margin improving
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | $135000 | $0 | — | — |
| Net income | -$15M | -$12M | -$25M | -$26M | -$12M | -$5M |
| Free cash flow | — | — | -$16M | -$10M | -$8M | -$5M |
| EPS (diluted) | $-2.74 | $-5.86 | $-6.63 | $-30.26 | $-37.00 | $-15.75 |
| Net margin | -678.2% | -984.6% | -18392.6% | — | — | — |
| ROIC | — | -87.9% | — | — | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 2 analysts is $10.00, 1093% above the current price; targets range from $8.00 to $12.00; the consensus rating is “Buy”; expected EPS is $-3.93 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is SeaStar Medical Holding stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 29% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does SeaStar Medical Holding pay a dividend?
Not currently.
Is SeaStar Medical Holding a good stock to buy?
We do not give buy or sell advice. SeaStar Medical Holding scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.